Clinical Study for Huazhuo Tongmai Decoction in the Treatment of Primary Hyperlipidemia Complicated with Carotid Atherosclerosis

Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1) Accord with the diagnostic criteria of hyperlipidemia: accord with any of the following: TC (> 6.22 mmol/L); 2.26 mmol/L (= TG (= 5.63 mmol/L);
•2) LDL-C (> 4.14 mmol/L);
•3) Accord with the diagnostic criteria of carotid atherosclerosis;
•4) TCM syndrome differentiation belongs to phlegm stagnation syndrome;
•5) Aged between 30 and 70 years;
•6) The research program is approved and signed by the ethical committees of clinical research. The patient knows and voluntarily signs the informed consent;
•7) Those who have stopped taking lipid-lowering drugs for more than 4 weeks or met the above criteria at the end of the introduction period.

•1) Pregnant or lactating women, allergic constitution and drug allergy;
•2) Patients who have suffered from acute myocardial infarction, cerebrovascular accident, severe trauma or major surgery within six months;
•3) Secondary hyperlipidemia;
•4) Hyperlipidemia and homozygous hypercholesterolemia caused by drugs (phenothiazines, beta-blockers adrenocorticosteroids and some contraceptives, etc.);
•5) Patients who are using heparin, thyroxine or other drugs that affect lipid metabolism, and those who have taken other lipid-lowering measures in the past two weeks;
•6) Psychiatric patients with severe primary diseases such as liver, kidney and hematopoietic system.

发起方

Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine